Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Synairgen PLC (GB:SNG)
LSE:SNG
Holding GB:SNG?
Track your performance easily
SNG Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range3.00p - 11.00p
Previous Close4.63p
Volume42.96K
Average Volume (3M)249.64K
Market Cap
£9.38M
Enterprise Value-6.54M
Total Cash (Recent Filing)£15.93M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta1.65
Next Earnings
Mar 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding201,374,975
10 Day Avg. Volume139,998
30 Day Avg. Volume249,644
Standard Deviation0.69
R-Squared0.17
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)57.38
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Synairgen News
PremiumCompany Announcements
Synairgen Expands Share Capital with New IssuancePremiumCompany Announcements
Synairgen Appoints New Chairman, Advances Antiviral Treatment
PremiumCompany Announcements
Synairgen Prepares for Pivotal Phase 2 Trial
PremiumCompany Announcements
Synairgen Appoints New Chairman, Eyes Future Growth
PremiumCompany Announcements
Synairgen Announces Upcoming Board Changes
PremiumCompany Announcements
Synairgen Prioritizes SNG001 Development, Eyes Phase 2 TrialSNG FAQ
What was Synairgen PLC’s price range in the past 12 months?
Synairgen PLC lowest share price was 3.00p and its highest was 11.00p in the past 12 months.
What is Synairgen PLC’s market cap?
Currently, no data Available
When is Synairgen PLC’s upcoming earnings report date?
Synairgen PLC’s upcoming earnings report date is Mar 13, 2025 which is in 107 days.
How were Synairgen PLC’s earnings last quarter?
Synairgen PLC released its earnings results on Sep 26, 2024. The company reported -0.016p earnings per share for the quarter, missing the consensus estimate of N/A by -0.016p.
Is Synairgen PLC overvalued?
According to Wall Street analysts Synairgen PLC’s price is currently Overvalued.
Does Synairgen PLC pay dividends?
Synairgen PLC does not currently pay dividends.
What is Synairgen PLC’s EPS estimate?
Synairgen PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synairgen PLC have?
Synairgen PLC has 202,660,690 shares outstanding.
What happened to Synairgen PLC’s price movement after its last earnings report?
Synairgen PLC reported an EPS of -0.016p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.794%.
Which hedge fund is a major shareholder of Synairgen PLC?
Currently, no hedge funds are holding shares in GB:SNG
---
Synairgen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.10%
12-Months-Change
Fundamentals
Return on Equity
-54.24%
Trailing 12-Months
Asset Growth
-43.12%
Trailing 12-Months
Company Description
Synairgen PLC
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, LOXL2 inhibitor, and others.
---
Technical Analysis
---